Skip to content

RAAP Advocacy Highlight

STOP: Accelerated Approval As A Proxy For High Drug Costs Is Misguided

The Rare Access Action Project, (RAAP) submitted comments to the Oregon Health Authority’s (OHA) proposed renewal and amendment of its Section 1115 waiver for the July 1, 2022 – June 30, 2027, demonstration period…

...Read More

RAAP is proud to have run the below ad in print papers as we work to protect innovations.

  • Who We Are
  • Initiatives
  • Resources
  • Events
  • Media
  • Contact
  • Quorum
© copyright 2021 RARE ACCESS ACTION PROJECT | Privacy Policy